REFERENCES
- Boulon, S. et al. 2010. HSP90 and its R2TP/Prefoldin-like cochaperone are involved in the cytoplasmic assembly of RNA polymerase II. Mol. Cell 39:912–924.
- Chen, C. D. et al. 2004. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10:33–39.
- Cloutier, P. et al. 2009. High-resolution mapping of the protein interaction network for the human transcription machinery and affinity purification of RNA polymerase II-associated complexes. Methods 48:381–386.
- Cloutier, P., and B. Coulombe. 2010. New insights into the biogenesis of nuclear RNA polymerases? Biochem. Cell Biol. 88:211–221.
- Delgermaa, L. et al. 2004. Subcellular localization of RPB5-mediating protein and its putative functional partner. Mol. Cell. Biol. 24:8556–8566.
- Deplazes, A., N. Mockli, B. Luke, D. Auerbach, and M. Peter. 2009. Yeast Uri1p promotes translation initiation and may provide a link to cotranslational quality control. EMBO J. 28:1429–1441.
- Djouder, N. et al. 2007. S6K1-mediated disassembly of mitochondrial URI/PP1γ complexes activates a negative feedback program that counters S6K1 survival signaling. Mol. Cell 28:28–40.
- Dorjsuren, D. et al. 1998. RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol. Cell. Biol. 18:7546–7555.
- Feldman, B. J., and D. Feldman. 2001. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1:34–45.
- Freeman, B. C., S. J. Felts, D. O. Toft, and K. R. Yamamoto. 2000. The p23 molecular chaperones act at a late step in intracellular receptor action to differentially affect ligand efficacies. Genes Dev. 14:422–434.
- Gstaiger, M. et al. 2003. Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI. Science 302:1208–1212.
- Guicciardi, M. E., and G. J. Gores. 2008. Cell stress gives a red light to the mitochondrial cell death pathway. Sci. Signal. 1:pe9.
- Jeronimo, C. et al. 2007. Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Mol. Cell 27:262–274.
- Kirchner, J. et al. 2008. Drosophila Uri, a PP1α binding protein, is essential for viability, maintenance of DNA integrity and normal transcriptional activity. BMC Mol. Biol. 9:36.
- Le, T. T. et al. 2005. Mutational analysis of human RNA polymerase II subunit 5 (RPB5): the residues critical for interactions with TFIIF subunit RAP30 and hepatitis B virus X protein. J. Biochem. 138:215–224.
- Markus, S. M. et al. 2002. Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol. Biol. Cell 13:670–682.
- Mellinghoff, I. K., and C. L. Sawyers. 2004. TORward AKTually useful mouse models. Nat. Med. 10:579–580.
- Nwachukwu, J. C. et al. 2009. Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. Cancer Res. 69:3140–3147.
- Oxelmark, E. et al. 2006. The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion. Mol. Cell. Biol. 26:5205–5213.
- Parusel, C. T., E. A. Kritikou, M. O. Hengartner, W. Krek, and M. Gotta. 2006. URI-1 is required for DNA stability in C. elegans. Development 133:621–629.
- Rai, J. S., M. J. Henley, and H. L. Ratan. 2010. Mammalian target of rapamycin: a new target in prostate cancer. Urol. Oncol. 28:134–138.
- Shang, Y., M. Myers, and M. Brown. 2002. Formation of the androgen receptor transcription complex. Mol. Cell 9:601–610.
- Taneja, S. S. et al. 2004. ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J. Biol. Chem. 279:13944–13952.
- Taylor, B. S. et al. 2010. Integrative genomic profiling of human prostate cancer. Cancer Cell 18:11–22.
- Thomas, M. A., D. M. Preece, and J. M. Bentel. 2010. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3′ untranslated region. Biochem. J. 425:575–583.
- Tomlins, S. A. et al. 2007. Integrative molecular concept modeling of prostate cancer progression. Nat. Genet. 39:41–51.
- Tomlins, S. A. et al. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644–648.
- Tronnersjo, S. et al. 2007. The jmjN and jmjC domains of the yeast zinc finger protein Gis1 interact with 19 proteins involved in transcription, sumoylation and DNA repair. Mol. Genet. Genomics 277:57–70.
- Vainberg, I. E. et al. 1998. Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell 93:863–873.
- Wei, W. et al. 2003. Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP). Cell Res. 13:111–120.
- Wysocka, J., P. T. Reilly, and W. Herr. 2001. Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol. Cell. Biol. 21:3820–3829.
- Xu, Y., S. Y. Chen, K. N. Ross, and S. P. Balk. 2006. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and posttranscriptional increases in cyclin D proteins. Cancer Res. 66:7783–7792.
- Yart, A. et al. 2005. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol. Cell. Biol. 25:5052–5060.